Safety of Bosentan in Type II Diabetic Patients

Clinical trial NCT04068272 · COMPLETED

Trial details

NCT number: NCT04068272
Sponsor: Retinset SL
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus

Start date: 2019-09-07
Primary completion: 2022-05-20
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.